Impact BioMedical, Inc. (IBO)
4.68
-0.16
(-3.31%)
USD |
NYAM |
Oct 06, 16:00
4.62
-0.06
(-1.28%)
After-Hours: 20:00
Impact BioMedical Price to Book Value : 3.714 for Oct. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 3.714 |
| October 05, 2026 | 3.841 |
| October 02, 2026 | 4.222 |
| October 01, 2026 | 4.309 |
| September 30, 2026 | 4.444 |
| September 29, 2026 | 4.444 |
| September 28, 2026 | 4.452 |
| September 25, 2026 | 4.516 |
| September 24, 2026 | 4.484 |
| September 23, 2026 | 5.261 |
| September 22, 2026 | 5.284 |
| September 21, 2026 | 5.565 |
| September 18, 2026 | 5.909 |
| September 17, 2026 | 5.723 |
| September 16, 2026 | 4.988 |
| September 15, 2026 | 5.298 |
| September 14, 2026 | 4.848 |
| September 11, 2026 | 4.609 |
| September 10, 2026 | 4.417 |
| September 09, 2026 | 4.944 |
| September 08, 2026 | 5.008 |
| September 04, 2026 | 5.408 |
| September 03, 2026 | 4.807 |
| September 02, 2026 | 4.907 |
| September 01, 2026 | 4.587 |
| Date | Value |
|---|---|
| August 31, 2026 | 4.618 |
| August 28, 2026 | 4.444 |
| August 27, 2026 | 4.417 |
| August 26, 2026 | 4.408 |
| August 25, 2026 | 4.609 |
| August 24, 2026 | 4.537 |
| August 21, 2026 | 4.807 |
| August 20, 2026 | 4.500 |
| August 19, 2026 | 4.338 |
| August 18, 2026 | 4.707 |
| August 17, 2026 | 4.781 |
| August 14, 2026 | 4.600 |
| August 13, 2026 | 4.407 |
| August 12, 2026 | 4.477 |
| August 11, 2026 | 4.306 |
| August 10, 2026 | 4.362 |
| August 07, 2026 | 4.358 |
| August 06, 2026 | 4.515 |
| August 05, 2026 | 4.306 |
| August 04, 2026 | 4.407 |
| August 03, 2026 | 4.397 |
| July 31, 2026 | 4.306 |
| July 30, 2026 | 4.306 |
| July 29, 2026 | 4.271 |
| July 28, 2026 | 4.306 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| LENZ Therapeutics, Inc. | 0.543 |
| Enveric Biosciences, Inc. | 0.7158 |
| ANI Pharmaceuticals, Inc. | 2.751 |
| Corcept Therapeutics, Inc. | 18.28 |
| Veru, Inc. | 1.484 |
Price to Book Value Related Metrics
| PS Ratio | 880.52 |
| Price | 4.68 |
| Earnings Yield | -26.48% |
| Market Cap | 39.98M |